Rheumatology Advisory Board Member

Rheumatology Advisory Board MemberThis advisory role is designed for nationally respected rheumatologists who bring deep expertise in clinical governance, multidisciplinary autoimmune disease program development, quality oversight, and health system strategy. The position supports the advancement of structured, high performing rheumatology service lines within evolving and growth-oriented healthcare environments.While clinical expertise may span inflammatory arthritis, connective tissue diseases, systemic autoimmune disorders, metabolic bone disease, and complex immunologic conditions, the rheumatologist’s perspective is essential in shaping standardized care pathways, biologic and advanced therapy stewardship, infusion program integrity, and population-based autoimmune care strategies.As a Rheumatology Advisory Board Member, you will provide strategic oversight to ensure expanding rheumatology programs uphold clinical rigor, evidence based standards, operational scalability, regulatory alignment, and measurable patient outcomes. This role partners closely with executive leadership, specialty service line administrators, pharmacy and therapeutics leadership, infusion services, quality and safety committees, and data strategy teams to strengthen governance frameworks and support responsible, performance driven growth.The advisory focuses on building sustainable, patient centered rheumatology models that balance innovation with safety, compliance, financial stewardship, and enterprise-wide accountability across outpatient clinics, hospital consult services, infusion centers, and integrated delivery systems.This position is ideal for a physician leader committed to advancing system level excellence in rheumatologic care while supporting strategic expansion, quality transparency, and long-term specialty sustainability.About Alzheimer’s Treatment Centers of America (ATCA) Alzheimer’s Treatment Centers of America (ATCA) leverages Artificial Intelligence (AI) and Personalized Precision Medicine to transform the treatment of Alzheimer’s disease, dementia, and cognitive impairment, including brain fog associated with Long COVID. This is about delivering structured, data driven treatment to patients today. ATCA goes beyond traditional diagnosis to identify underlying contributors to neurodegeneration and cognitive dysfunction, implementing individualized treatment protocols designed to slow progression and improve functional outcomes.Our multidisciplinary leadership team includes experienced healthcare executives, neuroscientists, AI engineers, and clinical specialists working together to deploy a scalable, neurologist supported clinic model nationwide. As we expand, we are building a governance framework supported by senior physician leaders who understand clinical rigor, operational scalability, and health system integration.Why Now? Growing Community Need: Our Palm Beach Gardens/Jupiter clinic is fully operational and actively treating patients in a high visibility medical corridor adjacent to Cleveland Clinic. Originally launched in a former urgent care space to enable rapid deployment, the clinic reached capacity quickly, with appointments booked months in advance reflecting significant unmet demand for proactive cognitive care.Three additional clinics are in development, with broader national expansion underway. ATCA is building a repeatable, specialist supported specialty model that expands access to structured cognitive evaluation and longitudinal management while maintaining clinical rigor and operational scalability.Seamless System Integration: ATCA’s care model integrates within the existing healthcare ecosystem. Treatments are reimbursed by Medicare, Medicare Advantage, and most major commercial insurers, reducing barriers to access and accelerating patient adoption.Focused on Outcomes: In a study utilizing ATCA’s AI driven protocol, 75% of patients with mild cognitive impairment demonstrated no further cognitive decline. This represents a data driven, proactive approach that complements traditional management pathways and emphasizes measurable outcomes.Advanced Therapeutic Options: Eligible patients may have access to TB006, an FDA approved therapy available for compassionate use, providing a potential treatment pathway for certain dementias, including Alzheimer’s disease.Physician Supported: ATCA’s protocols are backed by an experienced Medical Advisory Board of top doctors and scientists. As we expand nationally, we are strengthening this advisory infrastructure with senior surgical leaders who bring expertise in clinical governance, quality assurance, scalability, and system-based care delivery. See our Medical Advisory Board:https://atca.ai/medical-advisory-board/Key Achievements Proprietary AI Precision Engine: ATCA has built and deployed a defensible AI driven precision medicine platform that optimizes Alzheimer’s treatment at the individual patient level, creating strong clinical differentiation and long-term data network effects. High Margin, Replicable Clinic Model: Engineered a scalable specialty clinic platform targeting 44% EBITDA margins, driven by optimized staffing ratios, high-acuity service mix, and strong reimbursement dynamics designed for rapid multi-market expansion. Massive, Underserved Market Opportunity: Positioned to capture share in a $355B U.S. Alzheimer’s market and a $1.5T global opportunity, addressing one of the largest and fastest-growing unmet needs in healthcare.Embedded Revenue-Generating Research Infrastructure: Integrated micro research capabilities within each clinic to generate real world evidence, pharmaceutical partnerships, clinical trial participation, and recurring high margin ancillary revenue streams.Responsibilities Include Clinical Governance & Oversight: Provide strategic advisory leadership to ensure evidence based, standardized care across inflammatory arthritis, connective tissue disease, metabolic bone health, and complex autoimmune programs, including biologic stewardship and infusion safety aligned with ACR, EULAR, CMS, and regulatory standards.Service Line Strategy & Scalability: Advise on the design, optimization, and responsible expansion of rheumatology service lines, including centers of excellence, infusion programs, and integrated autoimmune care models to support sustainable growth and operational consistency.Quality & Outcomes Leadership: Guide disease activity measurement, threat to target implementation, steroid sparing strategies, biologic utilization oversight, registry participation, and performance reporting aligned with value-based care objectives.Interdisciplinary & Executive Collaboration: Partner with executive leadership, pharmacy, infusion services, specialty partners, and quality teams to ensure coordinated, patient-centered care delivery across outpatient, hospital, and integrated care settings.Innovation, Risk & Reimbursement Strategy: Provide oversight on emerging immunotherapies, digital monitoring tools, regulatory compliance, infusion economics, site of care strategy, and scalable growth while safeguarding clinical integrity and financial stewardship.Why Join Us? Strategic Influence: Shape the governance architecture of rapidly expanding AI enabled brain health platforms.Board Level Engagement: Contribute at the advisory level without day to day operational responsibility.Impact at Scale: Help ensure innovative cognitive care models expand responsibly while preserving the highest standards of neurosurgical oversight.Enterprise Level Perspective: Apply surgical leadership experience to one of the most urgent and fastest growing areas in healthcare.Clinical Integrity During Innovation: Safeguard rigor, accountability, and patient safety as precision medicine platforms scale nationally.Compensation / Perks Equity Participation Opportunities: Select advisory roles may include equity options aligned with long term strategic contribution.Strategic Investment Access: Advisory members may be offered optional participation in growth financing initiatives where applicable.Equal Opportunity Commitment We are committed to fostering inclusive advisory leadership. Diverse perspectives strengthen governance, innovation, and patient outcomes. Senior surgeons from all backgrounds are encouraged to participate in shaping the future of structured, scalable brain health care.